Reports preliminary Q3 revenue $3.33B, consensus $3.17B. Reports preliminary Q3 adjusted EBITDA $160M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health announces offering of 15M shares of common stock for holders
- BrightSpring Health price target raised to $32 from $26 at Mizuho
- Closing Bell Movers: BrightSpring Health up 6% on S&P 600 inclusion
- BrightSpring Health to replace Veritex in S&P 600 at open on 10/20
- BrightSpring Health price target raised to $32 from $25 at Morgan Stanley